Search research articles
Contact Us
Filters
Showing results (381-390 of 459) with videos related to
Page
of 46
Sort By:
Therapeutic Advances in Psychopharmacology
|
August 25, 2015
Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use
Suzanne Law, Peter M Haddad, Imran B Chaudhry, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 25, 2020
Dipyrrinato-Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation
Benjamin F Hohlfeld, Burkhard Gitter, Christopher J Kingsbury, et al.
Journal of Immunological Methods
|
March 4, 2014
Development of monoclonal antibodies to pre-haptoglobin 2 and their use in an enzyme-linked immunosorbent assay (ELISA)
J J Flanagan, A Arjomandi, M L Delanoy, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 2, 2024
Mortality associated with clozapine: what is the evidence?
Emilio Fernandez-Egea, Robert J Flanagan, David Taylor, et al.
Structure (London, England : 1993)
|
April 29, 1998
Human theta class glutathione transferase: the crystal structure reveals a sulfate-binding pocket within a buried active site
J Rossjohn, W J McKinstry, A J Oakley, et al.
Neuron
|
September 2, 2004
Analysis of Dscam diversity in regulating axon guidance in Drosophila mushroom bodies
Xiao-Li Zhan, James C Clemens, Guilherme Neves, et al.
International Journal of Oncology
|
April 8, 2010
Fatty acid synthesis is a therapeutic target in human liposarcoma
Arne M Olsen, Burton L Eisenberg, Nancy B Kuemmerle, et al.
The Journal of Biological Chemistry
|
October 25, 2000
Human glutathione transferase T2-2 discloses some evolutionary strategies for optimization of substrate binding to the active site of glutathione transferases
A M Caccuri, G Antonini, P G Board, et al.
Plos One
|
July 21, 2012
The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease
Richie Khanna, John J Flanagan, Jessie Feng, et al.
Plos One
|
November 9, 2013
Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin
Jennifer H E Baker, Alastair H Kyle, Kirsten L Bartels, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 459) with videos related to
Sort By:
Page
of 46
Therapeutic Advances in Psychopharmacology
|
August 25, 2015
Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use
Suzanne Law, Peter M Haddad, Imran B Chaudhry, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 25, 2020
Dipyrrinato-Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation
Benjamin F Hohlfeld, Burkhard Gitter, Christopher J Kingsbury, et al.
Journal of Immunological Methods
|
March 4, 2014
Development of monoclonal antibodies to pre-haptoglobin 2 and their use in an enzyme-linked immunosorbent assay (ELISA)
J J Flanagan, A Arjomandi, M L Delanoy, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 2, 2024
Mortality associated with clozapine: what is the evidence?
Emilio Fernandez-Egea, Robert J Flanagan, David Taylor, et al.
Structure (London, England : 1993)
|
April 29, 1998
Human theta class glutathione transferase: the crystal structure reveals a sulfate-binding pocket within a buried active site
J Rossjohn, W J McKinstry, A J Oakley, et al.
Neuron
|
September 2, 2004
Analysis of Dscam diversity in regulating axon guidance in Drosophila mushroom bodies
Xiao-Li Zhan, James C Clemens, Guilherme Neves, et al.
International Journal of Oncology
|
April 8, 2010
Fatty acid synthesis is a therapeutic target in human liposarcoma
Arne M Olsen, Burton L Eisenberg, Nancy B Kuemmerle, et al.
The Journal of Biological Chemistry
|
October 25, 2000
Human glutathione transferase T2-2 discloses some evolutionary strategies for optimization of substrate binding to the active site of glutathione transferases
A M Caccuri, G Antonini, P G Board, et al.
Plos One
|
July 21, 2012
The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease
Richie Khanna, John J Flanagan, Jessie Feng, et al.
Plos One
|
November 9, 2013
Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin
Jennifer H E Baker, Alastair H Kyle, Kirsten L Bartels, et al.
Page
of 46